Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Non Operating Income (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Non Operating Income data on record, last reported at $1.7 million in Q3 2025.

  • For Q3 2025, Non Operating Income rose 25.61% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $4.8 million, down 20.55%, while the annual FY2024 figure was $5.6 million, 61.49% up from the prior year.
  • Non Operating Income reached $1.7 million in Q3 2025 per ASMB's latest filing, up from $895000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.7 million in Q3 2025 and bottomed at $58000.0 in Q1 2021.
  • Average Non Operating Income over 5 years is $739631.6, with a median of $609000.0 recorded in 2023.
  • Peak YoY movement for Non Operating Income: plummeted 94.42% in 2021, then surged 757.75% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $101000.0 in 2021, then surged by 477.23% to $583000.0 in 2022, then soared by 178.22% to $1.6 million in 2023, then crashed by 30.89% to $1.1 million in 2024, then skyrocketed by 50.49% to $1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $1.7 million in Q3 2025, $895000.0 in Q2 2025, and $1.1 million in Q1 2025.